Deirdre O'Keeffe

Title: Deirdre O'Keeffe: Innovator in Pharmaceutical Chemistry

Introduction

Deirdre O'Keeffe is a prominent inventor based in Tonbridge, GB. She has made significant contributions to the field of pharmaceutical chemistry, holding two patents that showcase her innovative spirit and dedication to advancing medical science.

Latest Patents

Her latest patents include the development of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate salt. This patent discloses various mesylate salts and solvates, along with processes for preparing these compounds, their compositions, and their applications in medicine. Another notable patent involves paroxetine derivatives, which covers piperidine compounds, their preparation processes, pharmaceutical compositions, and therapeutic uses.

Career Highlights

Deirdre O'Keeffe is currently associated with SmithKline Beecham Corporation, where she continues to contribute to groundbreaking research and development in pharmaceuticals. Her work has been instrumental in creating new therapeutic options for patients.

Collaborations

Throughout her career, Deirdre has collaborated with esteemed colleagues, including Andrew Simon Craig and Alan David Jones. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Deirdre O'Keeffe's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a key innovator in the field. Her work continues to impact the medical community positively.